Paula Soteropoulos, Chief Executive Officer at AKCEA THERAPEUTICS, INC. (AKCA), sold 33,574 shares at $32.11 ($1.1M) on 2019-04-05, disclosed to the SEC on 2019-04-09.
Open-market sale of $1.1M AKCA by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.11 | 30,000 | $963K | 89.3% |
| 2 | $32.17 | 1,787 | $57K | 5.3% |
| 3 | $32.17 | 1,787 | $57K | 5.3% |
| Total | $32.12 avg | 33,574 | $1.1M | 100% |
| Filing → |
| DNTH | SELL | 2026-03-26 | $2.2M | — | Filing → |
| QURE | SELL | 2024-06-17 | $11K | — | Filing → |
| QURE | SELL | 2023-06-20 | $43K | — | Filing → |